← Back to Clinical Trials
Recruiting NCT06673797

NCT06673797 Effects of Swiss Ball vs Frenkle Exercises on Static and Dynamic Balance in Ataxic CP

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06673797
Status Recruiting
Phase
Sponsor Riphah International University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 18 participants
Start Date 2024-09-24
Primary Completion 2024-11-24

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 8 Years
Study Type INTERVENTIONAL
Interventions
Effects of Swiss Ball exercisesEFFECTS OF FRENKEL EXERCISES ON STATIC AND DYNAMIC BALANCE IN ATAXIC CHILDREN WITH CEREBRAL PALSY

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 18 participants in total. It began in 2024-09-24 with a primary completion date of 2024-11-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Several studies have highlighted the significant impact of cerebral palsy, a prevailing neurological and musculoskeletal developmental disorder among childhood disabilities worldwide. Within the spectrum of cerebral palsy, ataxic CP stands as the least prevalent type, accounting for 5 to 10% of all cases. Individuals diagnosed with ataxic CP encounter difficulties in fine motor skills, precision, and coordination, and exhibit an unsteady gait, some of which are linked to compromised postural control and inadequate core stability. These issues culminate in functional limitations, heightening the risk of falls, and further contributing to the overall disability experienced by the patients. Consequently, there exists a need to prioritize research and develop targeted treatment protocols specifically for ataxic CP. It is crucial to emphasize the enhancement of postural control and coordination, with particular emphasis on improving static and dynamic balance during rehabilitation. Implementing Swiss ball exercises and Frenkel exercises in the rehabilitation protocol for children with ataxic cerebral palsy can significantly diversify treatment strategies. These exercises play a pivotal role in supporting these children to either sustain or regain their ability to function independently, reduce the risk of falls, and notably improve their overall well-being.

Eligibility Criteria

Inclusion Criteria: * Patients with having diagnosis of ataxic cerebral palsy * Age between 5 to 8 years. * GMFC level 2. * Both the genders were included Exclusion Criteria: * Visual Impairments and hearing loss * Mental retardation * Fixed contractures or deformities of the spine or extremities * Meningitis

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ Imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Rana Ali Raza Shoukat, MS*

PRINCIPAL INVESTIGATOR

Riphah International Univerisity

Frequently Asked Questions

Who can join the NCT06673797 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 8 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06673797 currently recruiting?

Yes, NCT06673797 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06673797 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06673797 clinical trial?

NCT06673797 is sponsored by Riphah International University. The principal investigator is Rana Ali Raza Shoukat, MS* at Riphah International Univerisity. The trial plans to enroll 18 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology